11 results
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx
Native Hawaiian or Pacific
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
with Inmagene Biopharmaceuticals (“Inmagene”) with respect to certain Asian countries.
The Company chairs a global joint steering committee composed … and Commercialization
We hold global development and commercialization rights to izokibep (excluding certain Asian countries including mainland China, Hong
10-Q
2ei29g8ut y934
15 Jun 23
Quarterly report
4:19pm
424B4
u01djw1zkx 2f1
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
p20iqds5
1 May 23
IPO registration (amended)
6:10am
CORRESP
o4aw4utdi9l
20 Apr 23
Correspondence with SEC
12:00am
S-1
oeh26k8kcoj hph
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next